Evidence map›Paper›PMID 42677397›Full record

ReviewChemical reviews2026

Protein Modifications for Cellular Protein Delivery.

Jan Vincent V Arafiles, Jonathan Franke, Palina Dubatouka, Luise Franz, Christian P R Hackenberger

Abstract readReview
In one paragraph

Review in Chemical reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jan Vincent V ArafilesLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) , Robert-Rössle-Straße 10, 13125Berlin, Germany.ORCID 0000-0002-7733-7563
Jonathan FrankeLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) , Robert-Rössle-Straße 10, 13125Berlin, Germany.
Palina DubatoukaLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) , Robert-Rössle-Straße 10, 13125Berlin, Germany.
Luise FranzLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) , Robert-Rössle-Straße 10, 13125Berlin, Germany.
Christian P R HackenbergerLeibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) , Robert-Rössle-Straße 10, 13125Berlin, Germany.ORCID 0000-0001-7457-4742

Funding

Alexander von Humboldt-Stiftung NADeutsche Forschungsgemeinschaft 387284271 (CRC1349)Deutsche Forschungsgemeinschaft 392923329 (RTG 2473)Deutsche Forschungsgemeinschaft 431232613 (CRC 1449)Deutsche Forschungsgemeinschaft 505618676 (ANR/DFG)Fonds der Chemischen Industrie NA
6 · The paper itself

Abstract

Intracellular delivery of functional proteins is emerging as a powerful strategy to interrogate and control cellular pathways with high spatial and temporal precision. Recent advances in chemical biology now enable the design of cell-permeable proteins through precise chemical and biochemical modification, bringing the field closer to achieving intracellularly targeted biologics as a "new class of drugs". By overcoming the limitations of genetic manipulation, researchers create solutions for basic research and medicine. In this review, we outline the key motivations that drive intracellular protein delivery. We highlight central mechanistic paradigms for protein entry, important parameters influencing protein delivery, and summarize analytical tools to assess successful delivery. We outline different chemical and biochemical conceptional approaches that resulted in breakthrough studies to achieve functional protein transport. Finally, we discuss ongoing efforts, highlighting the challenges for future research on protein delivery.

Indexed as

Drug Delivery SystemsProteinsAnimalsHumansProtein TransportProteins

Identifiers

PMID42677397
PMCPMC13523645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.